Order Article Reprints

Amin R, Muthuramu I, Aboumsallem JP, Mishra M, Jacobs F, De Geest B. Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload. International Journal of Molecular Sciences. 2017; 18(9):2012. https://doi.org/10.3390/ijms18092012

Amin, Ruhul, Ilayaraja Muthuramu, Joseph Pierre Aboumsallem, Mudit Mishra, Frank Jacobs, and Bart De Geest. 2017. "Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload" International Journal of Molecular Sciences 18, no. 9: 2012. https://doi.org/10.3390/ijms18092012

Amin, R., Muthuramu, I., Aboumsallem, J. P., Mishra, M., Jacobs, F., & De Geest, B. (2017). Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload. International Journal of Molecular Sciences, 18(9), 2012. https://doi.org/10.3390/ijms18092012